Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain

Size: px
Start display at page:

Download "Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain"

Transcription

1 Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain Folch C, Casabona J, Majó X, Brugal T, Meroño M, González V, and Working group REDAN IHRA s 21st International Conference. Liverpool 26 April 21

2 Where is Catalonia? Barcelona

3 Background In Catalonia foreign population in 2 accounted for less than 3 of the overall population and in 29 that percentage had increased up to 16. We have also observed an increase of the immigrant UDIs which probably have a greater vulnerability to infections due to risk factors such as marginality, social exclusion and low contact with drug and health services. IDUs in Catalonia have still a high HIV prevalence due to the dramatic epidemic in the late 8s. This along with a still high sexual risk behaviour makes knowing the ITS prevalence an important objective in order to decrease HIV and ITS transmission

4 Aims To describe HIV, HCV, Chlamydia trachomatis and Neisseria gonorrhoeae prevalences among IDUs recruited in Catalonia To describe Risk behaviour prevalences related to these infections To compare HIV, HVC and ITS and risk behaviour prevalences between Spanish and Immigrant drug injectors

5 Methodology 748 UDIs recruited from Harm Reduction Services in Catalonia October 28 December 29 Stratified sample by service and country Inclusion criterion: current injectors (Last 6 months) Anonymous interview with a structured questionnaire Collection of biological samples VIH and VHC C. Trachomatis and N. gonorrhoeae

6 Results Sample breakdown by country 7, 6, 58,7 5, 4, 3, 23,5 2, 1, 9,2 6,6,,8,1 1,1

7 Sociodemographics: Spanish n=439 Immigrants n=39 Total p Mean age (DE) 38,5 (7,1) 33,4 (6,9) 36,4 (7,5) <,1 Men 78,1 88, 82,2 <,1 Living in Barcelona 8, 95,1 86,2 <,1 University degrees 1,1 18,3 8,2 <,1 Working situation*: <,1 Working 22,6 24,1 23,2 Unemployed 4,6 56, 47, On Social benefits 28,1 4,9 18,5 Others (begging, stealing...) 8,8 15, 11,3 Ever in prison 67,8 58,9 64,1,12 * Last 6 months

8 Spanish n=439 Immigrants n=39 Total Accommodation (last 6 months) <,1 Own house 49,9 25,6 39,8 Hostel 8,9 15,2 11,5 House with other people 8,9 7,1 8,2 Without a fixed place 19,1 35,3 25,8 Prison 1,8 2,6 2,1 Squatted house 8, 11,3 9,4 Others 3,4 2,9 3,2 Living with (last 6 months):* Alone 29,8 48,9 37,7 <,1 Partner 24,1 23,1 23,7 ns Parents or relatives 35,8 7,8 24,2 <,1 Children 11,4 3,2 8, <,1 Friends or other adults 17,1 32,8 23,6 <,1 p * Non mutually exclusive categories

9 Drug consumption characteristics: Spanish n=439 Immigrants n=39 Total p Ever in treatment 93,6 74,4 85,7 <,1 Meant time of drug injection (DE) 18,1 (8,7) 1,8 (6,7) 15,1 <,1 Most often drug injected** <,1 Heroin 41,3 4,3 4,9 Cocaine 42,5 23,1 34,5 Heroin plus cocaine 16,2 35,7 24, Others* -,9,6 Injecting daily** 43,7 57,6 49,5 <,1 methadone, amphetamine, ketamine, morphine, buprenorphine, LSD, MDMA ** Last 6 months

10 Syringe sharing prevalences P<,1 Spanishs Immigrants ,5 42,9 51,5 Total ,5 19,2 19,4 23,3 22,3 22,9 1 Has ever shared Has accepted syringes (last 6 months) Has passed syringes (last 6 months)

11 Indirect sharing prevalences (Last 6 months)* with a used syringe * p>,5 Spanishs Immigranst Total ,9 5 49,9 54,9 52, Front/backloading Sharing other m aterial

12 Most usual places were syringes are obtained (last 6 months) p<,5 Potentially non sterile sources p<,5 2 1 Buying in pharmacy Most used source for 58 of Spaniards outreach worker NSP Consumption rooms Drug treat. or health facilities Colleagues Partner Drug dealer Most used source for 56 of immigrants Spanish Immigrants

13 Sexual behaviour (Last 6 months): Spanish n=439 Immigrants n=39 Total p Has had sexual intercourse 67,4 72,8 69,7 ns Heterosexual (stable partner) 47,2 5, 48,3 ns With UDI stabel partner* 41,5 44,2 42,6 ns With HIV + stable partner* 24,9 4, 16, <,1 Heterosexual (occasional partners) 31,9 37,9 34,4 ns Sex with clients 8,5 5,8 7,4 ns Homosexual 2,7 3,6 3,1 ns * base: 27 Spanish and 154 immigrants with stable partner

14 Use of condoms by type of sexual partner (Last 6 months) p>, Last sexual intercourse Stable partner Last 6 months sexual interc. p>, Last sexual interc. Occasional partner Last 6 month sexual interc. Spanish Immigrants Total 1 Clients p>,5 Last sexual interc. Last 6 month sexual interc.

15 Use of health services (last 6 months)* ITS centre Family planning centre Hospital Immigrants Spanish Private doctor Drug treatment Prison A&E rooms GP p<,5 * categorías no excluyentes

16 Prevalence of HIV, HVC and STI (biological samples)

17 By country Spanish Immigrants Total 1 HIV p<,1 1 HCV p=, ,2 74,4 74, ,4 34, Chlamydia trachomatis p=,49 1 Neisseria gonorrhoeae p=, ,4 3,6 2,6 2,9,3,7

18 By country and sex Sanish Men Spanish Women Immig. Men Immig. Women 1 HIV 1 HCV ,4 52,6 22,5 21, , ,1 62,2 P<,5 No sign No sign P=,6 3 STI urine ,9 6,3 3,3 8,1 P<,1 No sign

19 Conclusiones There is still a high prevalence of HIV, which is higher among Spanish injectors compared to immigrants. HCV prevalence is very high and similar between the two groups. Immigrants are younger with a shorter injecting career. They have a smaller social network and lower contact with health and drug services apart from harm reduction services. All these may increase their vulnerability to acquire these infections Health and drug treatment services should be more sensitive to the new cultural and ethnic diversity of our society Low prevalence of STI among this population, higher in immigrants. However condom use is low More and better sexual prevention education should be done, especially regarding condom use among stable partners HIV transmission is mainly by risk injecting behaviour We should still expand and improve our harm reduction strategies

20 Acknowledges REDAN WORKING GROUP CEEISCAT: Jordi Casabona, Cinta Folch; Anna Esteve, Alexandra Montoliu; Rafa Muñoz Servei Microbiologia HUGTiP: Victoria González, Elisabeth Bascuñana, Vicenç Ausina Agència de Salut Pública de Barcelona: M. Teresa Brugal, Albert Espelt, Carmen Vecino Sudirecció General de Drogodependències: Xavier Majó, Joan Colom Àmbit Prevenció: Mercè Meroño, Anna Altabas Harm reduction services: Barcelona: Sant Adrià del Besós L Hospitalet de L: Sta Coloma de G Badalona: Reus: Terrassa: Lleida: Constantí: Girona: Àmbit Prevenció (AP), SAPS, Baluard, CAS Vall d Hebrón; El Local Sant Adrià; AEC-Gris ASAUPA M CAS, ARSU AIDE, Alba Arrels, F Mercè Fontanilles Creu Roja IAS Interviewers: Carmen Stanescu; Constanza Daigre; Pau Freixa; Alba Mestres; Silvia Isabel Moreira; Fabio Boccali; Pedro Sánchez; Rosa Kistmacher; Karla Cornejero; Sebastián Riveros; Esteve Lafita; Marc Muñoz; Marta Pardell; Joan Obiols; Concepció Escué

High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing?

High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing? High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing? Cinta Folch on behalf of REDAN Study Group Viral Hepatitis Prevention

More information

Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia

Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia Folch C 1,3, Casabona J 1,3, Espelt A 2,3, Major X 4, Meroño M 5, Gonzalez V 1,6,

More information

Public drug policies Catalonia

Public drug policies Catalonia Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia

More information

One-step screening of active hepatitis C virus infection in the community through dried blood spots

One-step screening of active hepatitis C virus infection in the community through dried blood spots One-step screening of active hepatitis C virus infection in the community through dried blood spots V. Saludes 1,2, C. Folch 2,3, A. Morales-Carmona 4, L. Ferrer 2,3, L. Fernández 2,3, R. Muñoz 2,3, M.

More information

Measurement of sexual health outcomes among people who inject drugs: pilot study in Catalonia, Spain and Barnaul, Russia

Measurement of sexual health outcomes among people who inject drugs: pilot study in Catalonia, Spain and Barnaul, Russia Folch et al. BMC Public Health (2018) 18:187 DOI 10.1186/s12889-018-5065-x RESEARCH ARTICLE Open Access Measurement of sexual health outcomes among people who inject drugs: pilot study in Catalonia, Spain

More information

Strategies of drug users to avoid infection with hepatitis C

Strategies of drug users to avoid infection with hepatitis C With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike

More information

Harm reduction among drug users in Spain

Harm reduction among drug users in Spain Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández

More information

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT Needle Syringe Programs and Harm Reduction Services in Australia AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT - Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees The Australian

More information

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don

More information

Additional North Carolina Projects

Additional North Carolina Projects Additional North Carolina Projects William Zule, Dr.P.H. www.rti.org RTI International is a trade name of Research Triangle Institute Risk Groups Injecting drug users (IDUs) Non-injecting drug users (non-idus)

More information

PERFORMANCE AND IMAGE ENHANCING DRUGS

PERFORMANCE AND IMAGE ENHANCING DRUGS PERFORMANCE AND IMAGE ENHANCING DRUGS Injectors access to needle syringe programs Presented at the 2014 National Drug Trends Conference Sydney 20 October 2014 Dr Karen J Chronister Overview Background

More information

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal Henrique Barros Ministério da Saúde HIV Testing Knowledge of HIV serostatus has been increasingly

More information

Saskatchewan HIV Strategy: Social Network Approach

Saskatchewan HIV Strategy: Social Network Approach Saskatchewan HIV Strategy: Social Network Approach Dr. Johnmark Opondo MHO Provincial Leadership Team (PLT) CATIE Forum: New Science, New Directions in HIV and HCV September 18, 2013 Toronto, Canada A

More information

Poland nationalupdate

Poland nationalupdate Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in

More information

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014

More information

Harm Reduction Database Wales: Needle and Syringe provision

Harm Reduction Database Wales: Needle and Syringe provision Harm Reduction Database Wales: Needle and Syringe provision 2012-13 Public Health Wales would like to thank all those that contributed to the Harm Reduction Database Wales: NSP service users, NSP staff

More information

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016 New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology

More information

http://doi.org/0.5/5/5750e0ff6f Perth Gay Community Periodic Survey 00 Conducted by This is a survey of sexual practices of men who have had sex with another man in the last five

More information

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political

More information

Sexual Partners and Condom Use Attitude: Qualitative Findings among Injecting Drug Users in Hai Phong, Vietnam

Sexual Partners and Condom Use Attitude: Qualitative Findings among Injecting Drug Users in Hai Phong, Vietnam Sexual Partners and Condom Use Attitude: Qualitative Findings among Injecting Drug Users in Hai Phong, Vietnam 2 nd International Conference on HIV/AIDS, STDs & STIs Las Vegas, 2014 Tanvir Ahmed, PhD Candidate

More information

Thirty years of harm reduction in the Netherlands HCV elimination ahead?

Thirty years of harm reduction in the Netherlands HCV elimination ahead? Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther

More information

HIV Risk Behaviour in Irish Intravenous Drug Users

HIV Risk Behaviour in Irish Intravenous Drug Users Abstract HIV Risk Behaviour in Irish Intravenous Drug Users A. Dorman, E. Keenan, C. Schuttler, J. Merry, J. J. O Connor The Drug Treatment Centre Board, Trinity Court, 30/31 Pearse Street, Dublin 2. The

More information

Hepatitis prevention in the context of HIV prevention point work in Latvia

Hepatitis prevention in the context of HIV prevention point work in Latvia Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205. HIV prevention point network in Latvia: History; Location;

More information

Prevention services for minors in prisons

Prevention services for minors in prisons Prevention services for minors in prisons Iulia-Veronica Broasca Project Manager, ARAS-Romanian Association Against-AIDS Issues Up to 10% of all new HIV infections worldwide are attributed to injecting

More information

Dr Vivian Hope. Health Protection Agency, London. 19 th Annual Conference of the British HIV Association (BHIVA)

Dr Vivian Hope. Health Protection Agency, London. 19 th Annual Conference of the British HIV Association (BHIVA) 19 th Annual Conference of the British HIV Association (BHIVA) Dr Vivian Hope Health Protection Agency, London 16-19 April 2013, Manchester Central Convention Complex Prevalence of, and risk factors for,

More information

PrEP Home Checklist v1.0

PrEP Home Checklist v1.0 PrEP Home Checklist v1.0 Every Visit o Risk Reduction Counseling o Appropriate referrals and follow-ups (SW, Pharmacy, et al.) o For those on PrEP: o Assessment of PrEP adherence, side effects, ongoing

More information

Background Past Present Future

Background Past Present Future Background Past Present Future Background Early testing helps to prevent transmission and lowers the risk of severe health complications Programatic objective: To increase the percentage of HIV + persons

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

The Integrated Bio Behavioural Surveillance (IBBS) Survey 2009 Malaysia: Preliminary Findings

The Integrated Bio Behavioural Surveillance (IBBS) Survey 2009 Malaysia: Preliminary Findings The Integrated Bio Behavioural Surveillance (IBBS) Survey 2009 Malaysia: Preliminary Findings INES YAP Director of Evaluation and Development Malaysian AIDS Council Malaysia HIV Roundtable Discussion,

More information

M. Vall-Mayans a, *, M. Villa b, M. Saravanya a, E. Loureiro a, M. Meroño c, E. Arellano a, B. Sanz a, P. Saladié a, A. Andreu b, M.G.

M. Vall-Mayans a, *, M. Villa b, M. Saravanya a, E. Loureiro a, M. Meroño c, E. Arellano a, B. Sanz a, P. Saladié a, A. Andreu b, M.G. International Journal of Infectious Diseases (2007) 11, 115 122 http://intl.elsevierhealth.com/journals/ijid Sexually transmitted Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV-1 infections in two

More information

Signs of success latest national NESI data?

Signs of success latest national NESI data? Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison

More information

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject

More information

Drug using mothers: retaining care of their children

Drug using mothers: retaining care of their children Drug using mothers: factors associated with retaining care of their children Gail Gilchrist 1 and Avril Taylor 2 1 L'Institut Municipal d'investigació Mèdica, Barcelona, Spain p g,, p 2 University of the

More information

Methods: respondent driven sampling (RDS) was used to recruit PWID

Methods: respondent driven sampling (RDS) was used to recruit PWID RDS study among PWID in Kohtla-Järve, north-east of Estonia: prevalence of HIV and risk behaviours (an update, based on 216 study, and methodological considerations) Maris Salekešin Sigrid Vorobjov Methods:

More information

Sexual relationships, risk behaviour, and condom

Sexual relationships, risk behaviour, and condom 368 Original article Department of Genitourinary Medicine, Charing Cross Hospital, Fulham Palace Road, London W6 8RF B A Evans Charing Cross and Westminster Medical School, Charing Cross Hospital, London

More information

Please note: If you filled in the form during a previous visit, you must not fill it in again!

Please note: If you filled in the form during a previous visit, you must not fill it in again! Appendix: Åse Haugstvedt, Eirik Amundsen, Rigmor C. Berg. Chemsex among men a questionnaire study. Tidsskriftet (Journal of the Norwegian Medical Association) 2018; 138. doi: 10.4045/tidsskr.18.0108 This

More information

First results collected by Argos, DCR in Strasbourg opened in november 2016

First results collected by Argos, DCR in Strasbourg opened in november 2016 Photo Marine Saiah First results collected by Argos, DCR in Strasbourg opened in november 2016 Danièle BADER, Leader of Ithaque Association EMCDDA, DRID Meeting 18-20 september 2017 A crossborder experimentation

More information

Young People and HIV/AIDS

Young People and HIV/AIDS Young People and HIV/AIDS Fact Sheet Young People at the Centre of HIV/AIDS Epidemic The fourth most populous country in the world with an estimated population of. million, Indonesia has 3% of its total

More information

I TRACK Survey. Report June 1, 2006

I TRACK Survey. Report June 1, 2006 I TRACK Survey Enhanced Surveillance of Risk Behaviours and Prevalence of HIV and Hepatitis C Among People Who Inject Drugs Report June 1, 2006 Prepared by: Epidemiology and Disease Control and Population

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.

More information

Australian Research Centre in Sex, Health & Society. EMBARGOED until am 4/8/09 Secondary Students and Sexual Health 2008

Australian Research Centre in Sex, Health & Society. EMBARGOED until am 4/8/09 Secondary Students and Sexual Health 2008 Australian Research Centre in Sex, Health & Society EMBARGOED until 10.30 am 4/8/09 Secondary Students and Sexual Health 2008 Melbourne, Australia Sample 2002 2008 Jurisdictions All All School sectors

More information

Gay Community Periodic Survey: Canberra 2015

Gay Community Periodic Survey: Canberra 2015 Gay Community Periodic Survey: Canberra 05 Never Stand Still Art Social Sciences Centre for Social Research in Health Peter Hull Limin Mao Keiran Rossteuscher Stephanie Marion-Landais Philippa Moss Garrett

More information

National HIV Behavioral Surveillance Portland, Oregon

National HIV Behavioral Surveillance Portland, Oregon National HIV Behavioral Surveillance Portland, Oregon Tim W. Menza, MD, PhD Medical Director HIV/STD/TB Section Oregon Health Authority timothy.w.menza@state.or.us National HIV Behavioral Surveillance

More information

Gay Community Periodic Survey: Melbourne 2017

Gay Community Periodic Survey: Melbourne 2017 Arts Social Sciences Centre for Social Research in Health Gay Community Periodic Survey: Melbourne 07 Centre for Social Research in Health Victorian AIDS Council Living Positive Victoria Department of

More information

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org

More information

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia Growing evidence in changing of usage, from natural plant substances to synthetic substances

More information

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EMCDDA-update HIV/HCV among people who inject drugs: situation and response EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis

More information

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe Sexually Transmitted Infections in Vulnerable Groups Kevin Rebe Definition: Key Populations Key populations are: Defined groups who, due to specific higher-risk behaviours, are at increased Men risk who

More information

THE REPUBLIC OF BELARUS

THE REPUBLIC OF BELARUS THE REPUBLIC OF BELARUS National Report on the Follow-up to the UNGASS Declaration of Commitment on HIV/AIDS Reporting period: January 2003 December 2005 Minsk 2005 TABLE OF CONTENTS 1. Situation at a

More information

Summary Report - IBBS Balochistan - Quetta Round 1, ROUND 1 SUMMARY REPORT -BALOCHISTAN QUETTA

Summary Report - IBBS Balochistan - Quetta Round 1, ROUND 1 SUMMARY REPORT -BALOCHISTAN QUETTA ROUND 1, 5-6 SUMMARY REPORT - BALOCHISTAN NATIONAL AIDS CONTROL PROGRAM BALOCHISTAN AIDS CONTROL PROGRAM CANADA PAKISTAN HIV/AIDS SURVEILLANCE PROJECT May 6 5-6 ROUND 1 SUMMARY REPORT -BALOCHISTAN QUETTA

More information

From Fix to Foil. The Dutch experience in promoting transition away from injecting drug use,

From Fix to Foil. The Dutch experience in promoting transition away from injecting drug use, From Fix to Foil The Dutch experience in promoting transition away from injecting drug use, 1991-2009 International Harm Reduction Conference Liverpool, April 2010 John-Peter Kools Contents 1. Dutch context

More information

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions

More information

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections

More information

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009 The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle

More information

Gay Community Periodic Survey Canberra 2011

Gay Community Periodic Survey Canberra 2011 Gay Community Periodic Survey Canberra 0 Never Stand Still Faculty of Arts and Social Sciences National Centre in HIV Social Research Peter Hull Limin Mao Keiran Rossteuscher Garrett Prestage Iryna Zablotska

More information

South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV

South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV 14 Original Article South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV Ojha S P 1, Sigdel S 2, H-G M 3, Verthein U 4 1 Tribhuvan University Teaching Hospital,

More information

New South Wales Needle and Syringe Program Enhanced Data Collection

New South Wales Needle and Syringe Program Enhanced Data Collection New South Wales Needle and Syringe Program Enhanced Data Collection 2017 A report for the NSW Ministry of Health by the Kirby Institute, UNSW Australia August 2017 Prepared by Ms Louise Geddes, Dr Jenny

More information

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a

More information

COUNTRY TABLE. MONTENEGRO.

COUNTRY TABLE. MONTENEGRO. EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI

More information

INTRAVENOUS INJECTING DRUG USE.

INTRAVENOUS INJECTING DRUG USE. Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been

More information

WHITEHORSE I-TRACK REPORT. Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon

WHITEHORSE I-TRACK REPORT. Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon WHITEHORSE I-TRACK REPORT Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon : Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon

More information

Formative Research results

Formative Research results FRR Annex 5: Presentation of the FR results in the project meeting, Berlin, 11. 13.02.2013 Formative Research results Sandra Dudareva Vizule, Ulrich Marcus Robert Koch Institute 11 February 2013 Content

More information

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia Part of the Continuum of Care Harm Reduction Gino Vumbaca President Harm Reduction Australia What is Harm Reduction The defining features are the focus on the reduction of harm, rather than on the prevention

More information

Update Report # 45. Patterns of Sexual Behaviors and Sexual Risk among HIV Positive People in New York City

Update Report # 45. Patterns of Sexual Behaviors and Sexual Risk among HIV Positive People in New York City Update Report # 45 Patterns of Sexual Behaviors and Sexual Risk among HIV Positive People in New York City Angela A. Aidala Mary Ann Chiasson Gunjeong Lee Center for Applied Public Health Joseph L. Mailman

More information

China Country Advocacy Brief Injecting Drug Use and HIV

China Country Advocacy Brief Injecting Drug Use and HIV United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific China Country Advocacy Brief Injecting Drug Use and HIV Key actions to be supported Expansion of the national

More information

Promoting hepatitis B vaccination

Promoting hepatitis B vaccination Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis

More information

Technical Guidance Note for Global Fund HIV Proposals

Technical Guidance Note for Global Fund HIV Proposals Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United

More information

Gay Community Periodic Survey: Perth 2016

Gay Community Periodic Survey: Perth 2016 Gay Community Periodic Survey: Perth 06 Never Stand Still Art Social Sciences Centre for Social Research in Health Evelyn Lee Limin Mao Matt Creamer Sue Laing Jude Comfort Garrett Prestage Iryna Zablotska

More information

Blood-borne viruses in marginalised populations

Blood-borne viruses in marginalised populations Blood-borne viruses in marginalised populations 2 May 2014 SYDNEY MEDICAL SCHOOL Bethany White, PhD Discipline of Addiction Medicine Overview Blood-borne viruses: HIV Hepatitis B virus (HBV) Hepatitis

More information

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,

More information

Harm Reduction in Nigeria

Harm Reduction in Nigeria Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous

More information

Co-Variation in Sexual and Non-Sexual Risk Behaviors Over Time Among U.S. High School Students:

Co-Variation in Sexual and Non-Sexual Risk Behaviors Over Time Among U.S. High School Students: Co-Variation in Sexual and Non-Sexual Risk Behaviors Over Time Among U.S. High School Students: 1991-2005 John Santelli, MD, MPH, Marion Carter, PhD, Patricia Dittus, PhD, Mark Orr, PhD APHA 135 th Annual

More information

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004 Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004 History of Syringe Exchange n Title 10 N.Y.C.R.R. 80.131 (a) (2), 80.135. n Enacted in 1992 in response to the HIV/AIDS

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result

More information

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a

More information

CONFERENCES CYCLE IN ENGLISH (1 st edition) Dr. Elisabet Vilella Pharmacogenomics and Genetics Unitat de Recerca. Hospital Pere Mata.

CONFERENCES CYCLE IN ENGLISH (1 st edition) Dr. Elisabet Vilella Pharmacogenomics and Genetics Unitat de Recerca. Hospital Pere Mata. (1 st edition) January 28 th, 2002 Dr. Elisabet Vilella Pharmacogenomics and Genetics Unitat de Recerca. Hospital Pere Mata. February 4 th, 2002 Dr. Manuel Mas-Bagà Therapeutic community and dual diagnosis

More information

Detection of Hepatitis B and C in Primary Care

Detection of Hepatitis B and C in Primary Care Detection of Hepatitis B and C in Primary Care Presentation 2 January 2016 Quality Quality Education Education for for aa Healthier Healthier Scotland Scotland 1 1 Learning Outcomes Participants will be

More information

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Joseph LARMARANGE - CEPED/IRD Symposium ANRS - AIDS 2012-23 July 2012 Epidemiological context» South America

More information

STIs and BBVs. The facts

STIs and BBVs. The facts EASY ENGLISH STIs and BBVs Some people say sex germs The facts New words There may be words in this factsheet that are new to you and you may not know what they mean or you may be unsure what they mean.

More information

Glossary of Acronyms. AIDS - Acquired Immunodeficiency Syndrome. CDC - Centers for Disease Control and Prevention. DHS - Department of Health Services

Glossary of Acronyms. AIDS - Acquired Immunodeficiency Syndrome. CDC - Centers for Disease Control and Prevention. DHS - Department of Health Services Acknowledgements This report was developed by the California Department of Health Services, Office of AIDS (DHS/OA) under cooperative agreement. U6/CCU965-- with support from the Centers for Disease Control

More information

UNGASS Indicators and possible adoption of NDPHS indicators. Tallinn /P.Leinikki

UNGASS Indicators and possible adoption of NDPHS indicators. Tallinn /P.Leinikki UNGASS Indicators and possible adoption of NDPHS indicators National Indicators 1. Committment and Action: 1. Domestic and international AIDS spending by categories and financing sources 2. National Composite

More information

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX European Surveillance of Sexually Transmitted Infections Survey questionnaire on STI surveillance, care and prevention in European countries APPENDIX Detailed questionnaire on clinician and laboratory

More information

HIV/AIDS Prevalence Among South African Health Workers, 2002

HIV/AIDS Prevalence Among South African Health Workers, 2002 HIV/AIDS Prevalence Among South African Health Workers, 2002 Presented at the Kwazulu/Natal INDABA on AIDS 2 December 2003 O. Shisana, Sc.D Executive Director, SAHA Human Sciences Research Council Introduction

More information

Review on HIV & Associated Infections in Latvia

Review on HIV & Associated Infections in Latvia Review on HIV & Associated Infections in Latvia Dr.Inga Upmace, Infectology Center of Latvia Second meeting on EG on HIV/AIDS and AI April 7, 2011, Riga Negative influences: Several reorganizations of

More information

HIV/AIDS INDICATORS. AIDS Indicator Survey 8 Basic Documentation Introduction to the AIS

HIV/AIDS INDICATORS. AIDS Indicator Survey 8 Basic Documentation Introduction to the AIS HIV/AIDS INDICATORS During the last decade there has been an increased effort to track the progress in the area of HIV/AIDS. A of international agencies and organizations have developed indicators designed

More information

Drug consumption among roma population

Drug consumption among roma population NATIONAL ANTIDRUG AGENCY Drug consumption among roma population High risk drug use and drug treatment in Europe 2014 Special populations and drug problems Lisbon, 24 September 2014 General characteristics

More information

Characteristics of cases of infectious syphilis diagnosed in prisons,

Characteristics of cases of infectious syphilis diagnosed in prisons, 34 Rev Esp Sanid Penit 2011; 13: 52-57 Characteristics of cases of infectious syphilis diagnosed in prisons, 2007-2008 C Garriga 1, 3, P Gómez-Pintado 2, M Díez 1, 3, E Acín 2, A Díaz 1, 3 1 Department

More information

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs, U N A I D S B E S T P R A C T I C E C O L L E C T I O N Drug use and HIV/AIDS UNAIDS statement presented at the United Nations General Assembly Special Session on Drugs Joint United Nations Programme on

More information

Key words: YIDUs, condom use behaviour

Key words: YIDUs, condom use behaviour Extended Absract Sexual risk behaviour among young injecting drug users in high HIV prevalence states of India: Evidence from IBBA Santosh Kumar Sharma (Ph.D. Scholor) International Institute for Poulation

More information

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set Sexually Transmitted Infection, including HIV, 213 Health Protection Scotland Slide Set Enhanced surveillance systems are employed to give more detailed information on the epidemiology of infectious syphilis

More information

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS KEY POPULATIONS PREVENTION INTERVENTIONS Ms E Marumo HIV PREVENTION STRATEGIES 13 June 2017 1 Background SA has about 7.1 million people living with HIV

More information

AUSTRALIAN NSP SURVEY

AUSTRALIAN NSP SURVEY AUSTRALIAN NSP SURVEY Prevalence of HIV, HCV and injecting and sexual behaviour among Needle and Syringe Program attendees 20 YEAR NATIONAL DATA REPORT 1995-2014 Report prepared by Jenny Iversen and Lisa

More information

Global AIDS Response Progress Report Myanmar. National AIDS Programme

Global AIDS Response Progress Report Myanmar. National AIDS Programme Global AIDS Response Progress Report Myanmar National AIDS Programme Reporting period: January 2014 December 2014 Submission date: 15 June 2015 Table of Contents 1. Status at a glance... 6 1.1 Reporting

More information

59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016

59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016 59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016 Accepted resolution to take to UNGASS 19-21 April We reiterate our commitment to end by 2030 the epidemics of AIDS and tuberculosis,

More information

Testing, Prevention and Care IDU in Chicago, 2009

Testing, Prevention and Care IDU in Chicago, 2009 HIV/HCV Risk Behaviors, Testing, Prevention and Care IDU in Chicago, 2009 Nik Prachand Britt Livak HIV Behavioral Surveillance IDU2 Cycle Surveillance, Epidemiology and Research Division of STI/HIV/AIDS

More information

Groups of young people in Uganda that need to be targeted with HIV interventions

Groups of young people in Uganda that need to be targeted with HIV interventions Module 5: HIV/AIDS and young people - Adolescent health and development with a particular focus on sexual and reproductive health - Assignment Peter James Ibembe Reproductive Health Uganda, Kampala, Uganda

More information

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 1. Introduction HIV/AIDS pandemic is a human, social and economic disaster, with far-reaching implications

More information

Responsibilities in a sexual relationship - Contact tracing

Responsibilities in a sexual relationship - Contact tracing P a g e 1 Responsibilities in a sexual relationship - Contact tracing This activity has been designed increase student familiarity with the NSW Health Play Safe website. Suggested duration: 50-60 minutes

More information

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and

More information